Texas Attorney General Ken Paxton is investigating two pharmaceutical companies for promoting the sale of hormone blockers to treat children with gender dysphoria even though the drugs are not approved for such purposes.
Endo Pharmaceuticals, Inc. and AbbVie Inc. are accused of violating the Texas Deceptive Trade Practices Act by promoting Supprelin LA and Lupron Depot. The drugs are licensed to treat what is known as precocious puberty, which is when children manifest hormonal changes at an early age.
When children four or older begin to manifest hormonal changes, these drugs are used to block hormones until the child reaches the age considered normal, after age 11-12, when the drug is stopped.
But the Texas prosecutor accuses the two drug companies of promoting these drugs for children with gender dysphoria, i.e., those who say they feel male when they have a female body and vice versa.
“Puberty blockers used on minors experiencing gender dysphoria or similar mental disorders is child abuse,” Paxton told Fox News.
“Doctors, parents, guardians, and counselors who aid and abet the use of puberty blockers in an improper manner are complicit in the abuse. As are prescription drug manufacturers, which is the basis of my investigation,” the conservative prosecutor added.
Currently, there are no drugs approved by the U.S. regulator, the FDA, to treat gender dysphoria, such as hormone blockers. However, many clinics and pro-LGBT organizations, and individuals prescribe them, promoting them as a solution for the condition.
For example, Planned Parenthood, the number one abortionist in the United States is currently one of the main providers of the hormone blocker Lupron. On the Mayo Clinic website, there is a section dedicated to promoting hormone blockers in adolescents suffering from gender dysphoria, downplaying its side effects.
In May of this year, a well-known Swedish clinic after decades of experience announced that it stopped prescribing hormone blockers in children with gender dysphoria due to the irreversible effects of the treatment.
Possible irreversible side effects include cardiovascular disease, osteoporosis, infertility, cancer, thrombosis and loss of bone density, a direct effect of disrupting hormonal growth.
Other studies have claimed those who undertook the treatment as teenagers, had sucicidal thoughts after adolescence. The rate of actual suicides in the transgender community is higher than those outside of it.
“Everyone involved in damaging our young people like this must be held accountable and brought to justice, and that’s exactly what I’m doing,” Dr. Paxton said.
One of the drugmakers, Endo Pharmaceuticals, denied the allegations, saying the company does “not have any approved medications indicated for gender dysphoria and we do not promote medications for off-label uses.”
In a press release, Paxton asserted that “The manufacture, sale, prescription, and use of puberty blockers on young teens and minors is dangerous and reckless. These drugs were approved for very different purposes and can have detrimental and even irreversible side effects. I will not allow pharmaceutical companies to take advantage of Texas children.”